LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) — Onco360(R), the nation's leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic(TM) (linvoseltamab-gcpt), which has been has granted accelerated approval by the Food and Drug Administration to treat adult patients with relapsed or refractory (R/R) multiple myeloma (MM) who […]

(NASDAQ:THRM), NOVI, Mich., Aug. 04, 2025 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the following upcoming investor events in the third quarter of 2025. J.P. Morgan Auto Conference in New York City Bill Presley, President

(NYSE:LRN), RESTON, VA, Aug. 04, 2025 (GLOBE NEWSWIRE) — Stride, Inc. (NYSE: LRN) has now partnered with Chama Valley Independent Schools and Santa Rosa Consolidated Schools, to operate Destinations Career Academy of New Mexico (NMDCA), one of its K12-powered online public schools, starting this fall. With more than 3,000 students already enrolled for the upcoming

Cabot Corporation to Acquire Mexico Carbon Manufacturing S.A. de C.V. from Bridgestone Corporation GlobeNewswire August 04, 2025 BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) — Cabot Corporation (NYSE: CBT) announced that it has entered into a definitive agreement to acquire Mexico Carbon Manufacturing S.A. de C.V. (MXCB) from Bridgestone Corporation. The reinforcing carbons manufacturing facility was

(NASDAQ:CLOV), New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in hospitalizations (15% lower) and 30-day readmissions (18% lower). WILMINGTON, Del., Aug. 04, 2025 (GLOBE NEWSWIRE) — Counterpart Health, Inc. (“Counterpart”), a

(NASDAQ:OLMA), SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to four new employees to purchase an aggregate of 130,000

(NASDAQ:BTOG), SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bit Origin Ltd (NASDAQ: BTOG) (“Bit Origin” or the “Company”) today announced that it has completed a reduction of its issued share capital, following the approval by its shareholders and subsequent confirmation by the Grand Court of the Cayman Islands. On June 5, 2025, the Grand Court

(NasdaqGM:RCKT), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). Shareholders who purchased shares of RCKT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

(NYSE:SOC), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Sable Offshore Corp. (NYSE: SOC). Shareholders who purchased shares of SOC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

(NasdaqGM:STIM), MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced that Keith Sullivan, President and Chief